Ladenburg initiated coverage of NeuroOne Medical (NMTC) with a Buy rating and $1.45 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMTC:
- NeuroOne Medical completes FDA submission for OneRF Ablation System RF
- NeuroOne Medical confirms ‘no material impact’ from global tariffs
- NeuroOne Medical sees FY25 product revenue $8M-$10M vs. $3.5M last year
- NeuroOne Medical’s OneRF technology featured in Fox News story
- NeuroOne Medical 16M share Spot Secondary priced at 50c